ClinicalTrials.gg
CompletedNCT04616794Updated Aug 24, 2026

Intervention on Modifiable Lifestyle Risk Factors for Dementia Prevention

An interventional study of Cognitive Engagement Group and Physical Activity Group in Risk Behavior and Cognitive Decline, sponsored by LuciLab. Completed at 1 site in Canada. Open to participants aged 50 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by LuciLab · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
41
Allocation
Non-randomized
Ages
50 Years to 70 Years
Sex
All
01

Study summary

The overarching aim is to develop and deploy a multidomain intervention delivered on a mobile application to help older adults reduce their risk for dementia by improving a set of modifiable lifestyle risk factors associated with cognitive decline/dementia. The targeted domains are physical activity, diet, and cognitively stimulating activity. This registration concerns the Proof-of-concept study which will examine if individual parts of the intervention program achieve a clinically significant degree of change in the targeted behavioral risk outcomes. It is expected that following the program, at least 50% of participants will show evidence of a clinically significant degree of change in the behavioral risk outcome targeted by the intervention, when compared to baseline.

Read the detailed description

There are encouraging indications from observational and prospective studies that late life multidomain lifestyle interventions can reduce the risk of cognitive decline and dementia, as well as improve cognition. However, these studies raise major issues related to scalability and adherence which can be addressed by relying on technology. These studies mainly used intensive and costly face-to-face interventions that are not easily implemented on a large scale. Furthermore, there are challenges with the adherence to all the components of a multi-domain lifestyle program.

Technology-delivered interventions have the potential to overcome some of the limitations of traditional face-to-face interventions. They confer numerous advantages including scalability of use in a real-world setting while limiting geographical constraints and other logistical challenges such as clinic attendance requirements. Such delivery modes also offer user convenience (e.g., undertaken at home and flexible schedule) and reduced costs associated with large-scale deployment of studies and programs.

In addition to the inclusion of technology, the success of health promotion interventions may also be improved by integrating models of lifestyle habit patterns and behaviour change determinants. The coach-based intervention will integrate behavioural change techniques based on the Behaviour Change Wheel developed by Michie. The coach intervention approach will also be guided by the Transtheoretical model of behaviour change principles proposed by Prochaska and DiClemente, and Motivational Interviewing techniques described by Rollnick and Miller.

The Proof-of-Concept study is a 10-week pre-post within-subject parallel group treatment-only study. There will be three single-domain groups (diet; physical activity or cognitive engagement), and one multidomain group. Participants will receive up to 9 weekly coach-assisted counselling sessions. The goal is to recruit up to 55 participants with at least one of the target risk factors : unhealthy diet, low level of cognitively stimulating activity or physical activity). Participants with a single risk factor will be invited to the single-domain condition for which they have a risk. Participants with multiple risk factors will be invited to the multidomain condition. The risk level for each domain will be examined before and after the intervention to assess whether the intervention has induced a clinically significant change.

02

Conditions studied

  • Risk Behavior
  • Cognitive Decline
03

In context

Risk-Taking

136 studies on the registry are indexed under Risk-Taking; 18 are open to participants now.

This study's enrollment of 41 is below the median of 255 across 117 interventional studies indexed under Risk-Taking.

Browse Risk-Taking studies →

Lead sponsor

LuciLab is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Proficient or native speakers in French;
  • Computer literate;
  • Committed not to participate in another program related to any of the three intervention domains for the duration of the trial;
  • At least one of the following:

    • Low cognitive engagement in cognitively stimulating activities, defined as a score ≤ 15 on the CAQ
    • Low level of physical activity defined as less than 600 MET-min/week (\~150 minutes/week) of MVPA measured using the IPAQ-SF
    • Low adherence to the Mediterranean-type diet defined as a score of ≤ 8 on the adapted Canadian MDS

Exclusion criteria

Exclusion Criteria

  • Presence of a cognitive impairment as measured by the Cogstate Brief BatteryTM ;
  • General anesthesia within the last 6 months;
  • Participation in any previous validation studies related to the program;
  • Participation, currently or within the last 6 months, in a program where they received any of the three interventions;
  • Unable to commit participation over the period of the study.
  • Participants in the precontemplation stage of change.
  • Participants with a high level of perceived stress.
  • Having received a diagnosis of:

    • Dementia or neurodegenerative disease;
    • Past or present neurological disorder;
    • Severe psychiatric disorder;
    • Uncontrolled cardiovascular or metabolic diseases;
    • Alcoholism or drug addiction;
    • Any other conditions expected to limit participation.

Domain-Specific exclusion criteria

  • Participants will be excluded from the physical activity intervention, but not the trial, if they have a medical to physical activity based on the Physical Activity Readiness Questionnaire
  • Individuals with dietary restrictions due to medical reasons, allergies or severe intolerance or an history of eating disorders will be excluded from participation in the healthy diet intervention.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
41 participants (actual)

Study arms

  • Experimental
    Cognitive Engagement Group

    Participants eligible to enter this group must show low cognitive engagement in cognitively stimulating activities, defined as a score \< 22 on the Cognitive Activity Questionnaire (CAQ)

    Behavioral: Cognitive Engagement Group

  • Experimental
    Physical Activity Group

    Participants eligible to enter this group must have a low level of physical activity defined as less than 600 MET-min/week (\~150 minutes/week) of moderate to vigorous physical activity (MVPA), measured using the International Physical Activity Questionnaire - short form (IPAQ-SF)

    Behavioral: Physical Activity Group

  • Experimental
    Diet Group

    Participants eligible to enter this group must have a low adherence to the Mediterranean-type diet defined as a score of ≤ 8 on the adapted Canadian Mediterranean Diet Scale (MDS).

    Behavioral: Diet Group

  • Experimental
    Multi-modal Group

    Participants eligible to enter this group must be eligible for at least two of the three single-arm conditions.

    Behavioral: Multimodal group

Interventions

  • BehavioralCognitive Engagement Group

    Participants in this group will be encouraged to lead a cognitively stimulating lifestyle, as a means for cognitive decline/dementia risk reduction. This will be achieved by providing educational materials, practical tips and strategies, and suggestions about the different options to increase cognitively stimulating activities and by assisting participants outlining goals to progressively adopt a more cognitively active lifestyle.

  • BehavioralPhysical Activity Group

    Participants in this group will be encouraged to lead a physically active lifestyle, as a means for cognitive decline/dementia risk reduction. This will be achieved by providing educational materials, practical tips and strategies, and suggestions about the different options to increase physical activities and by assisting participants outlining goals to progressively adopt a more physically active lifestyle.

  • BehavioralDiet Group

    Participants in this group will be encouraged to adopt a healthy diet, as a means for cognitive decline/dementia risk reduction. This will be achieved by providing educational materials, practical tips and strategies, and suggestions about the different options to change their diet and by assisting participants outlining goals to progressively adopt a Mediterranean-like diet.

  • BehavioralMultimodal group

    Participants assigned to this group will select which domain they wish to tackle first. Interventions are as described for the single-domain interventions.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Cognitive Engagement at study end

    Cognitive engagement is measured using the Cognitive Activity Questionnaire (CAQ). Participants are asked to indicate the frequency in which they engage in 10 cognitive leisure activities. Scores range from 0 to 70. A higher score represents a higher cognitive engagement level.

    Time frame: Baseline (within 1 week before the first coaching session) and study end (within 1 week after the last coaching session)

  2. Change from Baseline in Mediterranean Diet Adherence at study end

    Adherence to the Mediterranean Diet is measured with an adaptation of the Canadian Mediterranean Diet Scale (MDS). The scale consists of 13 questions on food consumption frequency and intake habits. Scores range from 0 to 13, where a higher score represents a higher adherence level.

    Time frame: Baseline (within 1 week before the first coaching session) and study end (within 1 week after the last coaching session)

  3. Change from Baseline in Physical Activity at study end

    Physical activity level is measured using the International Physical Activity Questionnaire - Short Form (IPAQ-SF). The IPAQ-SF consists of 7 items to assess Moderate to vigorous physical activity (MVPA) as well as walking and sitting time in the last 7 days. An overall total physical activity score is computed in Metabolic equivalent tasks (MET)-minutes/week, where a higher MET value represents a higher level of physical activity.

    Time frame: Baseline (within 1 week before the first coaching session) and study end (within 1 week after the last coaching session)

Secondary outcomes

  1. Change from Baseline in Luci Cognitive Engagement Score at study end

    Six questions are added to the Cognitive Activity Questionnaire to include stimulating cognitive activities not covered in the original questionnaire. From the whole questionnaire, a total score is computed ranging from 0 to 112, where a higher score represents a higher cognitive engagement level.

    Time frame: Baseline (within 1 week before the first coaching session) and study end (within 1 week after the last coaching session)

  2. Change from Baseline in Luci Mediterranean Diet Adherence Score at study end

    Eight questions are added to the Canadian Mediterranean Diet questionnaire to include food groups and food intake habits not covered in the original questionnaire. From the whole questionnaire, a total score is computed ranging from 0 to 36, where a higher score represents a higher adherence level.

    Time frame: Baseline (within 1 week before the first coaching session) and study end (within 1 week after the last coaching session)

  3. Change from Baseline in Luci Physical Activity Score at study end

    Three questions assess frequency and intensity of specific physical activities related to aerobic, resistance and flexibility training over the past 7 days. Three subscores and a total score ranging from 0-30 are computed, where higher scores represent higher physical activity levels.

    Time frame: Baseline (within 1 week before the first coaching session) and study end (within 1 week after the last coaching session)

  4. Goal Attainment

    For each goal, level of attainment and perceived effort towards goal attainment are rated weekly using a 10-point Likert-like scale, where 10 represents "completed" and "maximal effort", respectively.

    Time frame: Weekly (within 1 week after the first coaching session) up to study end (within 1 week after the last coaching session)

  5. Perceived Progress in adopting lifestyle changes

    Perceived Progress in adopting lifestyle changes will be investigated with a single question, "To what extent do you think you changed your (domain specified) lifestyle since the beginning of the program?", using a 10-point Likert-like scale, where 10 represents a major change.

    Time frame: Study end (within 1 week after the last coaching session)

  6. Change from Baseline in Readiness to change at study end

    Readiness to change will be determined using a 6-item questionnaire at Baseline and a 3-item questionnaire at study end.

    Time frame: Baseline (within 1 week before the first coaching session) and study end (within 1 week after the last coaching session)

  7. Satisfaction with the Program

    Satisfaction with the program is assessed using a 34-item questionnaire. This questionnaire includes questions derived from the end-user version of the Mobile App Rating Scale (uMARS), from the Satisfaction and Continuance Usage Intention Questionnaire, from the the Client Evaluation of Motivational Interviewing (CEMI), from the Behaviour Change Counselling Index (BECCI) as well as study-specific questions. Scores range from 0-5, where a higher score represents a higher satisfaction.

    Time frame: Study end (within 1 week after the last coaching session)

  8. Program Usability

    The usability of the program is assessed using the System Usability Scale (SUS). The SUS is a 10-item questionnaire. Scores range from 0-5, where a higher score represents a higher usability.

    Time frame: Study end (± 1 week after the last coaching session)

  9. Overall User Experience

    Feedback about the overall user experience with the platform will be collected using a semi-structured interview conducted by phone.

    Time frame: Study end (within 1 week after the last coaching session)

  10. Platform usage

    Continuous measures of different parameters linked to platform usage during the study period will be recorded and analyzed, including pattern of use (e.g., time of day), frequency (e.g., number of platform access), duration of use (e.g., duration of the coach sessions) and the functionalities used (e.g., content viewed).

    Time frame: Baseline (within 1 week before the first coaching session) to study end (within 1 week after the last coaching session)

07

Study locations

1 site
  • Sylvie Belleville
    Montreal, Quebec H3W 1W5, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04616794
Lead sponsor
LuciLab
Collaborators
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal, Sojecci II Ltd
Responsible party
Sponsor
First posted
Nov 5, 2020
Start date
Oct 13, 2020
Primary completion
Dec 24, 2020
Completion
Jan 15, 2021
Last update
Aug 24, 2026

Study contacts

Sylvie Belleville, PhD
principal investigator · Centre de recherche de l'Institut Universitaire de gériatrie de Montréal

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion